Comparison of Survival of Human Dermis, AlloDerm and Terudermis Graft in Nude Mous.
- Author:
Dae Soong PARK
1
;
Han Koo KIM
;
Seung Han KIM
;
Seung Hong KIM
;
Tae Jin LEE
Author Information
1. Department of Plastic and Reconstruction Surgery, College of Medicine, Chung-Ang University, Seoul, Korea. pds@chungang.md
- Publication Type:Original Article
- Keywords:
AlloDerm;
human dermis;
Terudermis;
Graft survival
- MeSH:
Acellular Dermis;
Animals;
Biopsy;
Buttocks;
Cadaver;
Collagen;
Dermis*;
Epidermal Cyst;
Epidermis;
Graft Survival;
Hair Follicle;
Humans*;
Membranes;
Mice;
Mice, Nude;
Skin;
Tissue Donors;
Transplants*
- From:Journal of the Korean Society of Plastic and Reconstructive Surgeons
2002;29(3):188-197
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Numerous materials, both autologous and nonautologous, have been used for augmentation of sunken areas and each has its own limitations. The ideal material for augmentation should not be absorbed in any manner. This study is designed to assess the survival of human dermis, AlloDerm and Terudermis graft according to the volume and histologic change. Twenty four nude mice, weighing about 50 grams and of 5 weeks of age were used. Human dermis was obtained from patients' buttock for dermofat graft. AlloDerm is an acellular dermal matrix obtained from human cadaveric skin. Terudermis is a bilayer membrane composed of bovine collagen matrix and a silastic membrane which functions as the epidermis. Eight graft pieces standardized to 1x1x 0.1 cm size were used in each group. The prepared graft was implanted at the back of the nude mouse. Biopsy specimens from each implanted area were taken 1, 4, 12 and 24 weeks later. The initial volume of the graft was measured by immersing it in a 2 cc of normal saline and the volume of fluid displaced was recorded. The changes of graft volume during the graft period were measured by the same method. The initial shape of the graft was maintained up to 24th week in The AlloDerm graft group. The volume of each graft decreased from initial 0.16 ml to 0.06 ml(34% of initial volume) on the 24 th week in Human dermis, from 0.15 ml to 0.12 ml (74%) in AlloDerm , and from 0.15 ml to 0 ml (0%) in Terudermis . In the human dermis graft group, some epidermoid cysts derived in hair follicles, appeared on the 24th week in dermis. The original structure of human dermis and Terudermis disappeared but the structure of AlloDerm remained until the 24th week after implantation. Our experimental study suggests that AlloDerm could be a safe material as an implant for permanent augmentation. In addition, use of AlloDerm could eliminate the concern about defect of a donor site and avoid complications such as epidermoid cysts. However the choice of graft for augmentation should be remained to the clinical situations.
